Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sanofi-Synthelabo and Pfizer conclude agreement on divestment of Campto

July 1, 2004

Preliminary data on Exherin in patients with solid tumors

July 1, 2004

Celecoxib and a poxvirus-based vaccine improve survival in mice with multiple intestinal neoplasia

July 1, 2004

Palifermin NDA submitted for oral mucositis

July 1, 2004

Preclinical progress in DOS-47 development program

June 30, 2004

First of two phase I studies for SNS-595

June 30, 2004

Peregrine and Affitech achieve first milestone in collaboration

June 30, 2004

MediGene closes license agreement with U. Chicago for HSV technology

June 30, 2004

GVAX vaccines development update

June 30, 2004

Biocon Biopharmaceuticals expands product portfolio

June 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...